Effects of magnesium sulfate on the canine cardiovascular system complicating astemizole overdose

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 6, 1997, Pages 795-800

  Sugiyama, Atsushi ^a   Aye, Nu Nu ^a   Katahira, Seiichiro ^a   Hagihara, Atsushi ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Arrhythmia; Astemizole; Magnesium; Monophasic action potential; QT prolongation; Repolarization

Indexed keywords

ASTEMIZOLE; MAGNESIUM SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVERSION; DATA ANALYSIS; DOG; DRUG MEGADOSE; ELECTROCARDIOGRAM; ELECTROSTIMULATION THERAPY; HEART LEFT VENTRICLE OVERLOAD; HEART OUTPUT; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASTEMIZOLE; BLOOD PRESSURE; CARDIAC OUTPUT; CARDIAC PACING, ARTIFICIAL; DOGS; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; MAGNESIUM SULFATE; MALE; MYOCARDIAL CONTRACTION; TACHYCARDIA, VENTRICULAR;

EID: 0343052952     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199706000-00013     Document Type: Article

References (30)

1. Richards DM, Brogden RN, Heel RC, Speight TM, Avery GS. Astemizole: a review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1984;28:38-61.
2. 1-antagonist astemizole. Arzneimittelforschung 1983;33:381-8.
3. Leor J, Harman M, Rabinowitz B, Mozes B. Giant U waves and associated ventricular tachycardia complicating astemizole overdose: successful therapy with intravenous magnesium. Am J Med 1991; 91:94-7.
4. Simons FER, Kesselman MS, Giddins NG, Pelech AN, Simons KJ. Astemizole-induced torsade de pointes. Lancet 1988;2:624.
5. Rao KA, Adlakha A, Verma-Ansil B, Meloy TD, Stanton MS. Torsades de pointes ventricular tachycardia associated with overdose of astemizole. Mayo Clin Proc 1994;69:589-93.
6. Hoppu K, Tikanoja T, Tapanainen P, Remes M, Saarenpää-Heikkilä O, Kouvalainen K. Accidental astemizole overdose in young children. Lancet 1991;338:538-40.
7. Craft TM. Torsade de pointes after astemizole overdose. Br Med J 1986;292:660.
8. Broadhurst P, Nathan AW. Cardiac arrest in a young woman with the long QT syndrome and concomitant astemizole ingestion. Br Heart J 1993;70:469-70.
9. Wiley JF, Gelber ML, Henretig FM, Wiley CC, Sandhu S, Loiselle J. Cardiotoxic effects of astemizole overdose in children. J Pediatr 1992;120:799-802.
10. Hasan RA, Zureikat GY, Nolan BM. Torsade de pointes associated with astemizole overdose treated with magnesium sulfate. Pediatr Emerg Care 1993;9:23-5.
11. Bailie DS, Inoue H, Kaseda S, Ben-David J, Zipes DP. Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs. Circulation 1988;77: 1395-402.
12. Krasner BS, Girdwood R, Smith H. The effects of slow releasing oral magnesium chloride on the QTc interval of the electrocardiogram during open heart surgery. Can Anaesth Soc J 1981;28: 329-33.
13. Banai S, Tzivoni D. Drug therapy for torsade de pointes. J Cardiovase Electrophysiol 1993;4:206-10.
14. Hashimoto K, Haruno A, Matsuzaki T, Sugiyama A, Akiyama K. Effects of antiarrhythmic drugs on canine ventricular arrhythmia model: which electrophysiological characteristics of drugs are related to their effectiveness? Cardiovasc Drugs Ther 1991;5: 805-18.
15. Franz MR, Costard A. Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ. Circulation 1988;77:1177-84.
16. Franz MR. Bridging the gap between basic and clinical electrophysiology: what can be learned from monophasic action potential recordings? J Cardiovasc Electrophysiol 1994;5:699-710.
17. Tobin JR, Doyle TP, Ackerman AD, Brenner J. Astemizole-induced cardiac conduction disturbances in a child. JAMA 1991;266: 2737-40.
18. Sugiyama A, Xue Y, Hagihara A, Saitoh M, Hashimoto K. Characterization of magnesium sulfate as an antiarrhythmic drug. J Cardiovasc Pharmacol Ther 1996;1:243-54.
19. Euler DE. Effects of magnesium on ischemic and reperfusion arrhythmias in a canine model with diminished collateral blood flow. Cardiovasc Drugs Ther 1995;9:565-71.
20. Bazett HC. An analysis of the time relations of electrocardiogram. Heart 1918;7:353-70.
21. 1-receptor-antagonist drugs. N Engl J Med 1994;330:1663-70.
22. Adamantidis MM, Lacroix DL, Caron JF, Dupuis BA. Electrophysiological and arrhythmogenic effects of the histamine type 1-receptor antagonist astemizole on rabbit Purkinje fibers: clinical relevance. J Cardiovasc Pharmacol 1995;26:319-27.
23. 1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine. Circ Res 1995;76:110-9.
24. Michiels M, Van Peer A, Woestenborghs R, Heykants J. Pharmacokinetics and tissue distribution of astemizole in the dog. Drug Dev Res 1986;8:53-62.
25. Watanabe Y, Dreifus LS. Electrophysiological effects of magnesium and its interactions with potassium. Cardiovasc Res 1972;6:79-88.
26. Nattel S, Zeng FD. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibres. J Pharmacol Exp Ther 1984;229:283-91.
27. Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988;77:392-7.
28. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984;108:188-93.
29. Woods WT, Katholi RE, Urthaler F, James TN. Electrophysiological effects of magnesium on cells in the canine sinus node and false tendon. Circ Res 1979;44:182-8.
30. Hall SK, Fry CH. Magnesium affects excitation, conduction, and contraction of isolated mammalian cardiac muscle. Am J Physiol 1992;263:H622-33.